IOB - Delayed Quote USD

Gilead Sciences, Inc. (0QYQ.IL)

96.12

+0.41

+(0.42%)

At close: January 30 at 7:13:36 PM GMT

Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications

Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even greater value for Gilead as it advances innovations to prevent and treat life-threatening diseases. The expanded agreement aims to deliver greater cost leadership and productivity enhancement for Gilead while seeking to extract greater value from the existing relationship. Leveraging machine learning and generative AI within an

PR Newswire 14 hours ago

GILD

CTSH
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock

Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks yesterday

GILD
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts

In the most recent trading session, Gilead Sciences (GILD) closed at $93.85, indicating a -1.57% shift from the previous trading day.

Zacks 2 days ago

GILD
Gilead Sciences to Release Fourth Quarter & Full Year 2024 Financial Results on Tuesday, February 11, 2025

FOSTER CITY, Calif., January 28, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2024 financial results and 2025 guidance will be released on Tuesday, February 11, 2025, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s fourth quarter and full year 2024 financial results and provide a business update.

Business Wire 2 days ago

GILD
Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views?

The average brokerage recommendation (ABR) for Gilead (GILD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks 2 days ago

GILD
Why Gilead Sciences (GILD) Is One of the Best Humane Stocks to Invest in Now?

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other best humane stocks to invest in now. In recent years, the investment landscape has seen a significant shift towards socially responsible investing strategies. […]

Insider Monkey 6 days ago

GILD
GILD vs. ALNY: Which Stock Is the Better Value Option?

GILD vs. ALNY: Which Stock Is the Better Value Option?

Zacks 7 days ago

ALNY

GILD
Exploring High Growth Tech Stocks in January 2025

The United States market has experienced a notable upswing, climbing by 3.8% over the past week and achieving a 24% increase over the last year, with earnings forecasted to grow by 15% annually. In this favorable environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these positive market trends.

Simply Wall St. 8 days ago

BEIGF

ONC

GILD
Why Gilead Sciences (GILD) Outpaced the Stock Market Today

The latest trading day saw Gilead Sciences (GILD) settling at $92.96, representing a +1.22% change from its previous close.

Zacks 9 days ago

GILD

^GSPC
Is Gilead Sciences (GILD) Among Billionaire Steve Cohen’s Top Stock Picks?

We recently published a list of Billionaire Steve Cohen’s Top 15 Stock Picks. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other Billionaire Steve Cohen’s top stock picks. Steve Cohen is one of the most prominent and successful hedge fund managers in the world, known […]

Insider Monkey 9 days ago

GILD
Can Gilead Sciences Sustain Its Growth Momentum in 2025?

GILD has performed well in the past six months, with new drug approvals, positive data readouts and strong quarterly results. While the fundamentals look solid, we advise investors to remain on the sidelines at current levels.

Zacks 10 days ago

GILD
House of the Week: A Riverfront Retreat in Southeastern Connecticut

The sellers never planned on owning the 30.7-acre property in Lyme, but bought it after a boat deal fell through. Now it’s asking $15 million.

The Wall Street Journal 13 days ago

GILD
The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences

Salesforce, Shell and Gilead Sciences are included in this Analyst Blog.

Zacks 13 days ago

GILD

SHEL

CRM
Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others

Today's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Shell plc (SHEL) and Gilead Sciences, Inc. (GILD).

Zacks 14 days ago

GILD

SHEL

GM
Is Gilead Sciences (GILD) Among the Best NASDAQ Dividend Stocks to Buy?

We recently published a list of 15 Best NASDAQ Dividend Stocks To Buy. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other best NASDAQ dividend stocks to buy. The NASDAQ, heavily comprised of technology stocks, has been on a consistent upward trajectory for some years. […]

Insider Monkey 14 days ago

GILD
Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?

Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.

Zacks 14 days ago

GILD
Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing

In the latest trading session, Gilead Sciences (GILD) closed at $92.38, marking a +1.52% move from the previous day.

Zacks 15 days ago

GILD

^GSPC
Gilead Sciences, US government settle patent case over HIV prevention drugs

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said in a statement that the agreement "allows Gilead to continue to focus its resources on its mission to discover, develop, and deliver innovative therapeutics to people with life-threatening diseases."

Reuters 15 days ago

GILD
Gilead, LEO Pharma Partner in $1.7 Billion Deal for Inflammatory Disease Therapies

Gilead gains global rights to oral STAT6 treatments.

GuruFocus.com 17 days ago

GILD
Gilead and LEO Pharma link on programmes for inflammatory conditions

LEO Pharma is eligible to receive up to $1.7bn in total payments, which include a $250m upfront payment.

Pharmaceutical Technology 17 days ago

GILD

Performance Overview

Return	0QYQ.IL	S&P 500
YTD	+4.08%	+2.78%
1-Year	+25.93%	+23.20%
3-Year	+61.01%	+36.99%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Gilead Sciences, Inc. (0QYQ.IL)

Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications

Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock

Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts

Gilead Sciences to Release Fourth Quarter & Full Year 2024 Financial Results on Tuesday, February 11, 2025

Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views?

Why Gilead Sciences (GILD) Is One of the Best Humane Stocks to Invest in Now?

GILD vs. ALNY: Which Stock Is the Better Value Option?

Exploring High Growth Tech Stocks in January 2025

Why Gilead Sciences (GILD) Outpaced the Stock Market Today

Is Gilead Sciences (GILD) Among Billionaire Steve Cohen’s Top Stock Picks?

Can Gilead Sciences Sustain Its Growth Momentum in 2025?

House of the Week: A Riverfront Retreat in Southeastern Connecticut

The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences

Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others

Is Gilead Sciences (GILD) Among the Best NASDAQ Dividend Stocks to Buy?

Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?

Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Gilead Sciences, US government settle patent case over HIV prevention drugs

Gilead, LEO Pharma Partner in $1.7 Billion Deal for Inflammatory Disease Therapies

Gilead and LEO Pharma link on programmes for inflammatory conditions

Performance Overview